Beiersdorf AG (Beiersdorf) manufactures, markets, and sells skin care, personal care, and self-adhesive products. The company classifies its business operations into two reportable segments: Consumer and Tesa.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Beiersdorf’s R&D arm focuses on development of new products with high potential and sustainable growth. In the Consumer business segment, the company develops innovative and high-quality skin care products. In the Tesa business segment, the company develops innovative adhesive tapes and self-adhesive solutions for industry, commercial customers, and end consumers. The company also aims to develop sun care products that prevent general skin cancer. As of December 2023, the company employed 1,686 people in its R&D division. In FY2023, the company had global portfolio of over 1,500 active patents around the world and 600 patent filings were in the ongoing grant procedure. It filed 60 new patents. The company operates research center in Hamburg, Germany. Beiersdorf performed 350 studies at the Beiersdorf study center with 8,000 participants and conducted 1,300 studies with 30,000 participants internationally. It also opened regional R&D laboratories in Brazil, China, India, and Japan. In FY2023, Beiersdorf incurred R&D expenses of EUR320 million, which as a percentage of revenue, stood at 3.3%.